PATHOGENESIS OF SARS LUNG DISEASE: IN VITRO STUDIES AND ANIMAL MODELS

The summary for the PATHOGENESIS OF SARS LUNG DISEASE: IN VITRO STUDIES AND ANIMAL MODELS Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	PATHOGENESIS OF SARS LUNG DISEASE: IN VITRO STUDIES AND ANIMAL MODELS
	CFDA Number:	93.838
	CFDA Description:	Lung Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-04-080
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Apr 05, 2004
	Creation Date:	Jan 09, 2007
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Feb 03, 2007
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) State governments Special district governments City or township governments Public housing authorities/Indian housing authorities Independent school districts Small businesses Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses County governments
Additional Information on Eligibility: Information not provided
Grant Description: The goal of this program announcement is to invite research applications to rapidly advance understanding of the pathogenesis of severe acute respiratory syndrome (SARS) in the lung using the following:o in vitro techniques (especially, using human viral isolates, human tissues and cells, and other biological samples) o existing animal models of related coronavirus infections (e.g., porcine respiratory CoV) o non-human primate models of SARSo new ferret models of SARSo new rodent models of SARSo other appropriate animal models of SARSThe PA invites R01 applications for both high risk hypothesis generating research and hypothesis driven projects (if sufficient preliminary data are available), relevant to the pathogenesis of human lung disease caused by the human SARS coronavirus (SARS-CoV).
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-04-080.html http://grants.nih.gov/grants/guide/pa-files/PA-04-080.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants: • Short-Term Institutional Training Grant for Clinician Scientists in Pediatric Respiratory, Sleep and...; • Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1); • Development and Testing of a Case Finding Methodology in COPD (R01); • Maximizing the Scientific Value of the NHLBI Biologic Specimen Repository: Scientific Opportunities ...; • Genomic Research in AAT-Deficiency and Sarcoidosis study (GRADS) Cooperative Research Project Grant:...; • Lung Response to Inhaled Highly Toxic Chemicals; • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01); • ASTHMA CLINICAL RESEARCH NETWORK; • COPD CLINICAL RESEARCH NETWORK; • NONHUMAN PRIMATE MODELS OF HIV-ASSOCIATED PULMONARY, CARDIOVASCULAR, AND HEMATOLOGICAL DISORDERS